Erik Wallstroem

20 papers receiving 1.2k citations

Erik Wallstroem's Hit Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis 2025 · 63 citations
630+8+17Years since publication250500750

Peers

Erik Wallstroem
Comparison fields: 5 of 75
  • Developmental Neuroscience 245
  • Pathology and Forensic Medicine 669
  • Neurology 270
  • Neurology 208
  • Immunology 292
Replace Daniele Carassiti with:
Daniele Carassiti United Kingdom
Stefanie Gaupp Germany
Christopher A. Halfpenny United Kingdom
John D. E. Parratt Australia
Robert Bonek Poland
Evgeniy Evdoshenko Russia
Pavel Štourač Czechia
Anja I. S. Moldenhauer Germany
Uschi Brehm Germany
Guillermo Izquierdo Ayuso Spain
Erik Wallstroem relative to Daniele Carassiti United Kingdom Daniele Carassiti's profile →
Citations per field
00.5×1.6×
Daniele Carassiti · 1×
Citations per year

Countries citing papers authored by Erik Wallstroem

Since Specialization
Citations

This map shows the geographic impact of Erik Wallstroem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wallstroem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wallstroem more than expected).

Fields of papers citing papers by Erik Wallstroem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wallstroem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wallstroem. The network helps show where Erik Wallstroem may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Wallstroem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Wallstroem Line = papers co-authored together Erik Wallstroem links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Hit paper breakdown →
2000778
2 2016182
3
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Hit paper breakdown →
202563
4 202458
5
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis
Hit paper breakdown →
202536
6 202319
7 202411
8 20158
9 20247
10 20246
11 20175
12 20215
13 20134
14 20234
15 20163
16 20252
17 20161
18 20171
19 20241
20 20251

About Erik Wallstroem

Erik Wallstroem is a scholar working on Neurology, Pathology and Forensic Medicine, Immunology, Genetics and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Immunotherapy and Immune Responses (2 papers), Lung Cancer Treatments and Mutations (2 papers), Hereditary Neurological Disorders (2 papers), Myasthenia Gravis and Thymoma (2 papers) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Developmental Neuroscience (245 citations), Pathology and Forensic Medicine (669 citations), Neurology (270 citations), Neurology (208 citations) and Immunology (292 citations). Erik Wallstroem has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Manfred Schmidbauer, Tomas P Olsson, Hans Lassmann, Andreas Stefferl, Christopher Linington, Robert Weissert, Maria K. Storch, Barbara Kornek, Eva Kubala Havrdova and Donald R. Johns. Their work appears in journals such as Neurology, New England Journal of Medicine, Multiple Sclerosis and Related Disorders, The Lancet Neurology and Pharmaceutical Statistics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact